Dr Shane Chittenden, DO | |
25359 Kinsale Pl, Aldie, VA 20105-3066 | |
(571) 228-9881 | |
Not Available |
Full Name | Dr Shane Chittenden |
---|---|
Gender | Male |
Speciality | Chiropractor - Orthopedic |
Location | 25359 Kinsale Pl, Aldie, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013334994 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111NX0800X | Chiropractor - Orthopedic | 0102202034 (Virginia) | Primary |
207ZF0201X | Pathology - Forensic Pathology | 20A12674 (California) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Shane Chittenden, DO 25359 Kinsale Pl, Aldie, VA 20105-3066 Ph: () - | Dr Shane Chittenden, DO 25359 Kinsale Pl, Aldie, VA 20105-3066 Ph: (571) 228-9881 |
News Archive
Not all kidney cancers behave the same, with wildly different responses to immunotherapy or other treatments – and wildly different outcomes for patients as a result.
Today's early morning highlights from the major news organizations, including articles on an inspector general's report on care at VA hospitals and growing pressure from some House Republicans to vote on an alternative to the Affordable Care Act.
SmartFigures are interactive figures that display data in the context of related results published in other papers and link figures to major biological databases.
IntelGenx Technologies Corp. ("IntelGenx") (TSX VENTURE:IGX)(OTCBB:IGXT) announced today that the Company's board of directors granted options to acquire 125,000 common shares effective November 24, 2009. All options were granted under the 2006 Stock Option Plan with an exercise price of C$0.65 and expire in five years.
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces the successful completion of preclinical toxicology testing on the gold nanoparticle carrier system that forms the fundamental basis for Emergex's entire infectious disease vaccine platform.
› Verified 4 days ago